RE: net risk reclassification P Values: valid or misleading?

J Natl Cancer Inst. 2014 Nov 27;107(1):355. doi: 10.1093/jnci/dju355. Print 2015 Jan.

Authors

Michael J Pencina¹, Benjamin Neely², Ewout W Steyerberg²

Affiliations

¹ Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Durham, NC (MJP, BN); Department of Public Health, Erasmus MC, Rotterdam, the Netherlands (EWS). michael.pencina@duke.edu.
² Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Durham, NC (MJP, BN); Department of Public Health, Erasmus MC, Rotterdam, the Netherlands (EWS).

PMID: 25432411
DOI: 10.1093/jnci/dju355

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor*
Humans
Models, Statistical*
Predictive Value of Tests*
Risk Assessment*

Substances

Biomarkers, Tumor